Oxaliplatin, Capecitabine, and Bevacizumab Followed By Surgery and/or Radiofrequency Ablation in Patients With Colorectal Cancer

NCT00408772 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Lack of accrual

Conditions

Colorectal Cancer
Metastatic Cancer

Interventions

BIOLOGICAL: bevacizumab
DRUG: capecitabine
DRUG: oxaliplatin
PROCEDURE: conventional surgery
PROCEDURE: neoadjuvant therapy
PROCEDURE: radiofrequency ablation

Sponsor

University of California, Davis

Collaborators

[object Object]